New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children

Poster Discussion
Chairs: M. Molina Molina (Hospitalet de Llobregat (Barcelona), Spain), R. Borie (Paris, France)

Prevalence of pleuroparenchymal fibroelastosis (PPFE): A retrospective single-centre case study S. Geleff (Vienna, Austria), J. Gmeiner (Vienna, Austria), P. Jaksch (Vienna, Austria), H. Prosch (Vienna, Austria)
Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis M. Toyoshima (Hamamatsu, Japan), A. Fukada (Hamamatsu, Japan), D. Akahori (Hamamatsu, Japan), T. Suda (Hamamatsu, Japan)
Traction bronchiectasis and platythorax on computed tomography are determinants of progression and mortality in pleuro-parenchymal fibroelastosis P. George (London, United Kingdom), D. Armstrong-James (London, United Kingdom), A. Devaraj (London, United Kingdom), E. Renzoni (London, United Kingdom), T. Maher (London, United Kingdom), A. Wells (London, United Kingdom), I. Pulzato (London, United Kingdom), P. Molyneaux (London, United Kingdom), M. Kokosi (London, United Kingdom), V. Kouranos (London, United Kingdom), G. Margaritopoulos (London, United Kingdom), S. Desai (London, United Kingdom), F. Chua (London, United Kingdom)
Multidisciplinary team dedicated to suspected heritable pulmonary fibrosis R. Borie (Paris, France), C. Kannengiesser (Paris, France), S. Amselem (Paris, France), O. Brugiere (Paris, France), D. Bouvry (Bobigny, France), A. Clement (Paris, France), V. Cottin (Lyon, France), P. Dieude (Paris, France), C. Dupin (Paris, France), R. Epaud (Creteil, France), L. Gouya (Paris, France), P. Fanen (Creteil, France), F. Sicre De Fontbrune (Paris, France), L. Wemeau-Stervinou (Lille, France), N. Nathan (Paris, France), B. Crestani (Paris, France)
Mid-term clinical course of the three Japanese SFTPC mutated familial interstitial pneumonia patients. H. Ito (Nagasaki, Japan), H. Nakaoka (Nagasaki, Japan), Y. Yamashita (Nagasaki, Japan), M. Takaki (Nagasaki, Japan), T. Tanaka (Nagasaki, Japan), M. Ishida (Kochi, Japan), K. Morimoto (Nagasaki, Japan)
Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer N. Nathan (Paris, France), M. Legendre (Paris, France), E. Filhol-Blin (Paris, France), R. Borie (Paris, France), D. Bouvry (Bobigny, France), C. Kannengiesser (Paris, France), K. Ahmad (Lyon, France), J. Albuisson (Paris, France), N. Allou (Saint Denis de la Réunion, France), K. Borensztajn (Paris, France), A. Butt (Paris, France), B. Copin (Paris, France), V. Cottin (Lyon, France), B. Crestani (Paris, France), J. Dalphin (Besancon, France), F. Dastot Le Moal (Paris, France), C. Delacourt (Lyon, France), P. De Vuyst (Brussels, Belgium), P. Duquesnoy (Paris, France), V. Giraud (Boulogne Billancourt, France), C. Gomez (Marseille Billancourt, France), L. Gouya (Colombes Billancourt, France), V. Nau (Paris, France), H. Nunes (Bobigny, France), C. Picard (Suresnes, France), G. Prevot (Toulouse, France), P. Reix (Lyon, France), M. Reynaud-Gaubert (Marseille, France), J. Traclet (Lyon, France), A. Coulomb L'Hermine (Paris, France), A. Clement (Paris, France), S. Amselem (Paris, France)
COPA syndrome restricted to life-threatening alveolar hemorrhages: clinical, pathological, molecular and biological characterization N. Nathan (Paris, France), M. Legendre (Paris, France), S. Amselem (Paris, France), A. Clement (Paris, France), E. Filhol-Blin (Paris, France), N. Richard (Paris, France), S. Roullaud (Angoulême, France), M. Fayon (Bordeaux, France), G. Rice (Manchester, United Kingdom), D. Duffy (Paris, France), V. Bondet (Paris, France), A. Coulomb L’Hermine (Paris, France), B. Neven (Paris, France), M. Fremond (Paris, France), Y. Crow (Paris, France)
Down syndrome and pulmonary hemosiderosis: an under-recognized association A. ALIMI (Paris, France), J. Taytard (Paris, France), R. Abou Taam (Paris, France), V. Houdouin (Paris, France), A. Forgeron (Le Mans, France), M. Lubrano Lavadera (Rouen, France), P. Cros (Brest, France), I. Gibertini (Tours, France), J. Derelle (Nancy, France), A. Deschildre (Lille, France), C. Thumerelle (Lille, France), R. Epaud (Créteil, France), P. Reix (Lyon, France), M. Fayon (Bordeaux, France), S. Roullaud (Angouleme, France), F. Troussier (Angers, France), M. Renoux (Montpellier, France), J. De Blic (Montpellier, France), S. Leyronnas (Paris, France), G. Thouvenin (Paris, France), C. Perisson (Paris, France), A. Ravel (Paris, France), A. Clément (Paris, France), H. Corvol (Paris, France), N. Nathan (Paris, France)
Exogenous lipoid pneumonia in African children: a mixed-methods case series D. Marangu (Nairobi, Kenya), K. Pillay (Cape Town, South Africa), E. Banderker (Cape Town, South Africa), A. Vanker (Cape Town, South Africa), D. Gray (Cape Town, South Africa), M. Zampoli (Cape Town, South Africa)
Alveolar hemorrhage syndrome in children A. Bogorad (Moscow, Russian Federation), Y. Mizernitsky (Moscow, Russian Federation), N. Rosinova (Moscow, Russian Federation), N. Lev (Moscow, Russian Federation), L. Sokolova (Moscow, Russian Federation), S. Djakova (Moscow, Russian Federation), I. Zorina (Moscow, Russian Federation), M. Kostiutchenko (Moscow, Russian Federation)
Effectiveness of inhibitor mTOR in patients with lymphangioleiomyomatosis. L. Novikova (Saint-Petersburg, Russian Federation), M. Ilkovich (Saint-Petersburg, Russian Federation), D. Dzadzua, (Saint-Petersburg, Russian Federation), O. Baranova (Saint-Petersburg, Russian Federation), M. Vasilyeva (Saint-Petersburg, Russian Federation)
Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) P. Le Guen (Paris, France), S. Chevret (Paris, France), E. Bugnet (Paris, France), C. De Margerie-Mellon (Paris, France), F. Jouenne (Paris, France), G. Lorillon (Paris, France), A. Seguin-Givelet (Paris, France), S. Mourah (Paris, France), D. Gossot (Paris, France), R. Vassallo (Rochester, United States of America), A. Tazi (Paris, France)
Cytokine profiling in Pulmonary Langerhans Cell Histiocytosis: novel insights into pathogenesis. S. Barril Farre (Barcelona, Spain), S. Hortelano (Madrid, Spain), A. Luque (Madrid, Spain), M. Higueras (Madrid, Spain), C. Rodriguez-Martin (Madrid, Spain), C. Robledo (Madrid, Spain), A. Feliu (Barcelona, Spain), P. Millan (Barcelona, Spain), O. Sibila (Barcelona, Spain), F. Alonso (Madrid, Spain), D. Castillo (Barcelona, Spain)
Pleural effusion in patients with IgG4-related disease: new insights from a case series O. Wand (Petah Tiqwa, Israel), O. Moreh Rahav (Petah Tiqwa, Israel), O. Shtraichman (Petah Tiqwa, Israel), M. Kramer (Petah Tiqwa, Israel)
Drug induced interstitial lung disease: a systematic review S. Skeoch (Manchester, United Kingdom), N. Weatherley (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), A. Oldroyd (Manchester, United Kingdom), C. Johns (Sheffield, United Kingdom), C. Hayton (Manchester, United Kingdom), A. Giollo (Leeds, United Kingdom), J. Wild (Sheffield, United Kingdom), J. Waterton (Manchester, United Kingdom), M. Buch (Leeds, United Kingdom), K. Linton (Manchester, United Kingdom), I. Bruce (Manchester, United Kingdom), C. Leonard (Manchester, United Kingdom), B. Stephen (Sheffield, United Kingdom), N. Chaudhuri (Manchester, United Kingdom)
Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression M. Nasser (Lyon, France), P. Rigaud (Lyon, France), K. Ahmad (Lyon, France), J. Traclet (Lyon, France), V. Cottin (Lyon, France)
Pulmonary Lymphangiomatosis – insights into an ultra-rare disease N. Sarmand (Heidelberg, Germany), S. Piel (Heidelberg, Germany), E. Brunnemer (Heidelberg, Germany), J. Waelscher (Heidelberg, Germany), M. Polke (Heidelberg, Germany), A. Warth (Heidelberg, Germany), C. Heussel (Heidelberg, Germany), M. Eichinger (Heidelberg, Germany), F. Lasistschka (Heidelberg, Germany), B. Hoegerle (Heidelberg, Germany), L. Frankenstein (Heidelberg, Germany), H. Zabeck (Heidelberg, Germany), S. Rieken (Heidelberg, Germany), F. Herth (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany)